 |
 |
 |
|
Backed by top international funds, Extera Capital provides expansion funds to international medical and life science product companies. Such companies offer attractive returns with moderate risk and short time to exit but do not fit aggressive return on investment or leverage opportunity expected by tradition private equity and venture investors. |
| |
